ARCHIVES

Abraxane and Gemcitabine Improves Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Hydridoma Cell Lines Available

March 5, 1982

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

Surgical Oncology Status A Disaster, DCT board Told; Kramer Describes Radiotherapy Needs

April 20, 1979

Fisher, Hallman Lecture At annual ASCO/AACR Meeting

May 9, 1980